STEP 2: Spasticity Live Course - April 26-27 in Rosemont, IL-Case-based Discussion: Spinal Cord Injury Paraplegia Leading to IBT

Case-based Discussion: Spinal Cord Injury Paraplegia Leading to IBT

Pdf Summary

Dr. Mary E. Russell, an expert in Physical Medicine and Rehabilitation at the University of Texas at Houston, discussed the application of Intrathecal Baclofen (ITB) therapy for managing spasticity in patients with spinal cord injury (SCI). The case study involved a 52-year-old female with severe global spasticity impacting her daily activities. Despite previous reluctance, the patient underwent an ITB screening test which resulted in reduced tone, improved balance, and decreased anxiety. The patient eventually received an ITB pump implant and successfully discontinued oral spasticity medications, leading to improved comfort and function. The treatment plan included flex dosing to tailor medication delivery to specific needs. While ITB therapy offers benefits such as global spasticity treatment and reduction of oral medication side effects, limitations like surgical implantation risks and the need for device replacements every few years exist. Monitoring and adjustments to dosing are crucial for optimal outcomes. Dr. Russell highlighted the importance of addressing both upper and lower limb spasticity and the potential side effects and risks associated with ITB therapy. The successful case study showcased the effectiveness of ITB therapy in managing spasticity and improving quality of life for patients with SCI.

Keywords

Dr. Mary E. Russell

Physical Medicine and Rehabilitation

University of Texas at Houston

Intrathecal Baclofen therapy

spasticity management

spinal cord injury

ITB screening test

flex dosing

oral spasticity medications

global spasticity treatment